TapewireFind a company

person · Reporting owner

Laube Lynne Marie

Disclosed activity across 3 companies

Tapewire entity
44108
SEC CIK
0001730687

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Aeries Technology, Inc.WWAC · Entity 7328DirectorOctober 19, 2021October 19, 2021
Cardlytics, Inc.CDLX · Entity 7603DirectorNovember 08, 2022November 10, 2022
NERDWALLET, INC.NRDS · Entity 2280DirectorMay 21, 2026May 26, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aeries Technology, Inc.

Report date October 19, 2021 · Filed October 19, 2021

This filing explicitly reported no securities owned.

Cardlytics, Inc.

Report date November 08, 2022 · Filed November 10, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect313,547 Reported balance After 2022-11-08 transaction · row 1
1 source row

Row 1 · 2022-11-08 · Sale · Disposed 4 · Balance 313,547

F1: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

Common StockSEC Table I · non-derivativeIndirectSee Footnote14,565 Reported balance Holding disclosure · report date 2022-11-08 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 14,565

F2: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.

Common StockSEC Table I · non-derivativeIndirectSee Footnote14,565 Reported balance Holding disclosure · report date 2022-11-08 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 14,565

F3: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.

Filing footnotes · ownership attribution and instrument terms

F1: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.

F2: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.

F3: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.

NERDWALLET, INC.

Report date May 21, 2026 · Filed May 26, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect79,627 Reported balance After 2026-05-21 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-05-21 · Grant · Acquired 19,494 · Balance 79,627

F1: Represents Restricted Stock Units ("RSUs") payable solely in Class A Common Stock of the Issuer.

F2: Includes 19,494 RSUs payable solely in Class A Common Stock of the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Represents Restricted Stock Units ("RSUs") payable solely in Class A Common Stock of the Issuer.

F2: Includes 19,494 RSUs payable solely in Class A Common Stock of the Issuer.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 10, 2018 Filed Dec 12, 2018 22:22 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-062264 · doc4.xml · derivative · entry 7

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock.

F8 · derivative.exercise_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs").

F8 · derivative.expiration_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs").

Read SEC document
December 10, 2018 Filed Dec 12, 2018 22:22 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 13,100 $13.69 $179,339.00
Disclosure

SEC source: 0001209191-18-062264 · doc4.xml · nonDerivative · entry 2

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 483,924

F3 · kind: Shares sold to satisfy withholding tax obligations upon the settlement of restricted stock grants.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.30 - $14.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.

Read SEC document
December 10, 2018 Filed Dec 12, 2018 22:22 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 75,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-062264 · doc4.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock.

F2 · balance_after: Includes 1,909 shares of the Common Stock acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
December 05, 2018 Filed Dec 7, 2018 21:53 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-061535 · doc4.xml · derivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). The PSUs have not yet settled.

F2 · derivative.expiration_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). The PSUs have not yet settled.

Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:13 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,349 $20.66 $27,870.34
Disclosure

SEC source: 0001209191-18-047742 · doc4.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,115

F1 · kind: Represents shares sold to cover taxes due upon the settlement of certain restricted stock unit grants.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 ConversionSeries G' Redeemable Convertible Preferred Stock · Derivative 18,325 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · derivative · entry 10

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,325 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative 1,193 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · derivative · entry 9

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,325

Underlying: Common Stock · 1,193 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 1,193 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · derivative · entry 8

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series G' Redeemable Convertible Preferred Stock · 1,193 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock.

F5 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering.

F5 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative 2,045 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · derivative · entry 7

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,132

Underlying: Common Stock · 2,045 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 2,045 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · derivative · entry 6

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series G' Redeemable Convertible Preferred Stock · 2,045 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock.

F5 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering.

F5 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative 1,104 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · derivative · entry 5

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,087

Underlying: Common Stock · 1,104 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionRestricted Stock Unit · Derivative 1,104 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · derivative · entry 4

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series G' Redeemable Convertible Preferred Stock · 1,104 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock.

F5 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering.

F5 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:26 UTC Cardlytics, Inc. CDLX · Entity 7603 ConversionCommon Stock 18,325 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-010400 · doc4.xml · nonDerivative · entry 1

Laube Lynne Marie · CIK 0001730687 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.